Vasa Therapeutics Announces Participation at the 36th Annual Oppenheimer Life Sciences Conference
PR Newswire —
ENCINITAS, Calif. and WROCLAW, Poland, Feb. 12, 2026 /PRNewswire/ -- Vasa Therapeutics ("Vasa"), a clinical stage biotechnology company developing novel therapies for cardiovascular and metabolic aging, today announced its participation at the 36th Annual Oppenheimer Life Sciences...